Rep Arrington: Bipartisanship legislation will make drug pricing

Arrington: Bipartisanship support needed to lower prescription costs

Posted: Updated:
LUBBOCK, Texas -

The House Ways and Means Committee has approved a drug pricing bill, with a vote expected next week. It would allow Medicare to negotiate lower costs with drug companies. The soaring cost of prescription meds and healthcare has been a divisive topic in congress.

"We all, Republican or Democrat, are for the objective of lowering the price of prescription drugs, especially for our seniors," said Lubbock Congressman Jodey Arrington. "They are way too high. And in some cases, completely out of control."

Congressman Arrington said the only way to solve the overpricing of prescription meds is with bipartisan support. The 'Lower Drug Costs Now Act', led by House Democrats, would reduce beneficiaries' premiums by $6 billion. It would also slash out-of-pocket costs by $25 billion and even lower drug prices in the commercial market. This is according to an analysis conducted by the non-partisan Congressional Budget Office.

Arrington said competition, transparency, and choice should instead be the solution to lowering prescription drug prices. He points out that big government solutions will hurt our country's quality of care.

"It will hurt access to care, especially for the most vulnerable," said Arrington. "I'm hoping, ultimately, we can get a bi-partisan solution. Right now it is very partisan because of the impeachment and because that is the direction that Speaker Pelosi has chosen to go."

Arrington suggests that this piece of legislation was rushed and has the potential of dying once it reaches the Senate; he believes it has no chance of becoming law. A house vote is expected next week.

Powered by Frankly
All content © Copyright 2000 - 2019 RAMAR. All Rights Reserved.
For more information on this site, please read our Privacy Policy, and Terms of Service, and Ad Choices.